Michael Spannagl Selected Research

Antithrombins

2/2014

Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Spannagl Research Topics

Disease

23	Hemorrhage 03/2021 - 05/2002
14	Thrombosis (Thrombus) 02/2022 - 01/2004
10	Hemophilia A (Haemophilia) 07/2021 - 06/2005
5	Stroke (Strokes) 01/2020 - 08/2010
5	Thrombocytopenia (Thrombopenia) 12/2019 - 12/2007
5	Infections 12/2017 - 01/2004
4	Wounds and Injuries (Trauma) 03/2021 - 11/2012
4	Neoplasms (Cancer) 01/2021 - 10/2008
4	von Willebrand Diseases (von Willebrand's Disease) 11/2019 - 02/2010
4	Venous Thromboembolism 01/2013 - 12/2007
3	Atherosclerotic Plaque (Atheroma) 01/2021 - 03/2019
3	Atrial Fibrillation 01/2020 - 05/2012
3	Virus Diseases (Viral Diseases) 09/2014 - 12/2010
3	Thrombophilia 01/2011 - 09/2005
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 12/2019
2	Myocardial Infarction 01/2020 - 08/2010
2	Aortic Valve Stenosis (Aortic Stenosis) 04/2018 - 05/2011
2	Acute Coronary Syndrome 08/2017 - 02/2009
2	Hepatitis C 09/2013 - 10/2009
2	Venous Thrombosis (Deep-Vein Thrombosis) 09/2005 - 01/2005
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Hemophilia B (Haemophilia B) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2019
1	Heart Failure 04/2019
1	Vascular Diseases (Vascular Disease) 12/2017
1	Drug-Related Side Effects and Adverse Reactions 10/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2015
1	Hepatitis B 09/2014
1	Antithrombin III Deficiency 02/2014
1	Leukemia 01/2014
1	Inflammation (Inflammations) 02/2013
1	Acquired Protein S Deficiency 02/2012

Drug/Important Bio-Agent (IBA)

7	Factor VIII (Coagulation Factor VIII)IBA 03/2021 - 01/2005
5	von Willebrand FactorIBA 02/2022 - 01/2005
5	emicizumabIBA 07/2021 - 04/2019
5	AntigensIBA 12/2015 - 01/2005
4	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020 - 06/2005
4	CollagenIBA 01/2020 - 01/2004
4	Heparin (Liquaemin)FDA LinkGeneric 12/2019 - 12/2007
4	AnticoagulantsIBA 09/2016 - 03/2009
3	Vitamin K FDA Link 01/2020 - 05/2012
3	CytokinesIBA 12/2017 - 10/2011
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 08/2017 - 07/2009
3	Thrombin FDA Link 05/2011 - 10/2008
3	fibrin fragment D (D-dimer)IBA 07/2008 - 01/2004
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 03/2019
2	PAR-1 ReceptorIBA 10/2020 - 01/2020
2	RivaroxabanIBA 10/2020 - 01/2020
2	Pharmaceutical PreparationsIBA 12/2019 - 09/2016
2	acalabrutinibIBA 12/2019 - 03/2019
2	ibrutinibIBA 12/2019 - 03/2019
2	SteroidsIBA 04/2019 - 04/2009
2	Prasugrel Hydrochloride FDA Link 08/2017 - 02/2013
2	TicagrelorIBA 08/2017 - 02/2013
2	Clopidogrel (Plavix)FDA Link 08/2017 - 02/2013
2	certoparin (certoparin sodium)IBA 01/2013 - 11/2012
2	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2012 - 05/2011
2	Fibrinogen (Factor I)FDA Link 12/2011 - 03/2010
2	Adenosine Diphosphate (ADP)IBA 05/2011 - 01/2004
1	remibrutinibIBA 01/2021
1	Factor Xa InhibitorsIBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 01/2020
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2020
1	Fc Receptors (Fc Receptor)IBA 12/2019
1	zanubrutinibIBA 12/2019
1	fenebrutinibIBA 12/2019
1	tirabrutinibIBA 12/2019
1	evobrutinibIBA 12/2019
1	platelet membrane glycoprotein VIIBA 03/2019
1	Toll-Like Receptor 3IBA 12/2017
1	Poly I-CIBA 12/2017
1	Protein CIBA 12/2017
1	Viral RNAIBA 12/2017
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2017
1	Purinergic P2Y Receptor AntagonistsIBA 08/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	IpilimumabIBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2015
1	AutoantigensIBA 12/2015
1	Interleukin-17 (Interleukin 17)IBA 12/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2015
1	HLA-C Antigens (HLA-C)IBA 12/2015
1	AntibodiesIBA 07/2015
1	cancer procoagulantIBA 07/2015
1	InterferonsIBA 09/2014
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	AntithrombinsIBA 02/2014
1	HLA-B Antigens (HLA-B)IBA 01/2014
1	EpitopesIBA 09/2013
1	HLA-A Antigens (HLA-A)IBA 09/2013
1	LipidsIBA 02/2013
1	argatroban (MPQA)FDA Link 04/2012
1	Protein SIBA 02/2012
1	Contraceptive Agents (Contraceptives)IBA 02/2012

Therapy/Procedure

8	Therapeutics 01/2020 - 06/2005
2	Stents 08/2013 - 02/2013
1	Cardiac Rehabilitation 04/2019
1	Secondary Prevention 08/2017
1	Drug-Eluting Stents 08/2013